Lenvervimab Biosimilar - Research Grade

Human

HBVï؟½

5mg/ml

IgG1 - kappa

CHO Cells

https://www.imgt.org/mAb-DB/

ICH3002

Blue ice

Reagents that engage the hepatitis B virus (HBV) surface antigen underpin a wide range of viral hepatitis and neutralization studies. This human IgG1, kappa antibody is an unconjugated, non-therapeutic analog of lenvervimab that binds the HBV antigen for functional and antiviral research. It is purified to low-endotoxin specifications appropriate for in vivo experiments and supplied in scalable milligram-to-gram quantities to keep high-throughput and bulk programs running. Marked for research use only (RUO), it serves as a positive binding control and active reagent in neutralization assays, antigen-capture workflows, in vitro screening, and preclinical models of HBV infection.

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

3-4 weeks